Death of the pressure patch has been slightly exaggerated
Death of the pressure patch has been slightly exaggeratedBest practice guidelines are just that—guidelines. They’re not religious dogma designed to herd everyone into the same line. We are rightly moving toward more evidence-based medicine, such as increased use of bandage lenses and less pressure patching in the management of corneal abrasions and erosions.
NSAIDs Linked to Increase in MI RiskStudy finds that all NSAIDs are associated with an increased risk of acute myocardial infarction.
Preparing your patient for PRKPhotorefractive keratectomy (PRK) was the original excimer laser procedure approved by the FDA—and is still a safe and effective treatment of refractive errors. PRK has the benefits of no-flap creation; therefore, there is no risk of flap complications.
Risks associated with omega-3 supplementation
Risks associated with omega-3 supplementationDuring my preoperative visit, my surgeon handed me a list of no less then 165 medications and supplements that I should stop taking 14 days prior to my surgery. Fish and krill oil were on the list, as were aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)—as expected.
Selecting topical regimens for cataract patients
Selecting topical regimens for cataract patientsEyecare practitioners who deal with patients in the perioperative period are well aware of the need for topical therapy. In most cases, a combination of a steroid, a nonsteroidal anti-inflammatory drug (NSAID), and an antibiotic will be used for a few days before the day of surgery and then for a period afterward.
Andexanet quickly reverses factor Xa inhibitor activity for DOACsAndexanet alpha is designed to reverse the anticoagulant effects of factor Xa inhibitors.
New osteoarthritis drug expands options for low-dose NSAIDsFDA approved meloxicam (Vivlodex, Iroko Pharmaceuticals, LLC) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain in 5-mg and 10-mg doses administered once daily.
NSAIDs and menstrual blood loss
NSAIDs and menstrual blood lossShould NSAIDs be first-line treatment for heavy menstrual bleeding?
CME rates lower with intravitreal transzonular antibiotic than topical NSAIDsThe rate of postoperative cystoid macular edema was lower in a recent study of nearly 1,000 cataract surgery patients at two sites using intravitreal transzonular antibiotic and steroid prophylaxis than in previous studies with topical administration.
Extending anticoagulation by 18 months lowers risk of PE recurrenceA recent study examined the benefits of extending warfarin therapy for an additional 18 months after an initial six-month treatment period.